Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

NCT04668209 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
31
Enrollment
OTHER
Sponsor class

Stopped After 15 months of active enrollment and a lack of qualifying hospitalized COVID-19 patients, the Sponsor-Investigator, Marilyn Csete Glassberg, MD, decided to terminate recruitment before meeting the stated enrollment objectives.

Conditions

Interventions

Sponsor

University of Arizona

Collaborators